Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

15 fruit fly brains in a colourful grid design © Gil Costa (www.gilcosta.com)

A large part of our genome is made up of potentially mobile pieces called transposons, also known as ‘jumping genes’ for their ability to change their position. While humans largely share the same genes in our DNA, the combination of transposons are unique for each person. Recent evidence uncovered in 2020 by Dr Christoph Treiber and Professor Scott Waddell in the Centre for Neural Circuits and Behaviour (CNCB) suggests that transposons are particularly active in the brain. This has given rise to a new hypothesis that transposons might change brain functions and contribute to the diversity of behaviours across individuals within a population.

Dr Christoph Treiber of the Waddell group has now been awarded a European Research Council (ERC) Starting Grant to begin an independent line of research to interrogate this hypothesis over the next five years. The award of more than £1.25 million will “help us understand whether our unique transposon fingerprint contributes to who we are. Transposons could be a key component of our personality.” (Dr Christoph Treiber).

With this new award, Dr Treiber will combine two novel and ground-breaking techniques to test the hypothesis in the fruit fly brain, a well-established model for studying how genes alter behaviours. The first, single-cell transcriptomics, has been pioneered by Dr Treiber and Dr Vincent Croset in the Waddell Group at the CNCB. The second, PacBio® single-molecule real-time (SMRT) sequencing generates full length cDNA sequences from cells and tissues.

Read the full story on the DPAG website. 

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.